C
Chris J. Malkin
Researcher at Royal Hallamshire Hospital
Publications - 28
Citations - 2337
Chris J. Malkin is an academic researcher from Royal Hallamshire Hospital. The author has contributed to research in topics: Testosterone (patch) & Heart failure. The author has an hindex of 14, co-authored 22 publications receiving 2157 citations.
Papers
More filters
Journal ArticleDOI
The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
TL;DR: Testosterone replacement shifts the cytokine balance to a state of reduced inflammation and lowers total cholesterol in men with symptomatic androgen deficiency.
Journal ArticleDOI
Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
Chris J. Malkin,Peter J. Pugh,John N. West,Edwin Jacques Rudolph van Beek,T. Hugh Jones,Kevin S Channer +5 more
TL;DR: Testosterone replacement therapy improves functional capacity and symptoms in men with moderately severe heart failure and the patch preparation was not well tolerated by the study patients.
Journal ArticleDOI
Androgens, insulin resistance and vascular disease in men
TL;DR: In this article, the authors have shown that testosterone levels are low in men with diabetes, visceral obesity (which is strongly associated with insulin resistance), coronary artery disease and metabolic syndrome.
Journal ArticleDOI
Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
Chris J. Malkin,Peter J. Pugh,Paul Morris,K E Kerry,Richard D. Jones,T. H. Jones,Kevin S Channer +6 more
TL;DR: Testosterone replacement therapy in hypogonadal men delays time to ischaemia, improves mood, and is associated with potentially beneficial reductions of total cholesterol and serum tumour necrosis factor α.
Journal ArticleDOI
Low serum testosterone and increased mortality in men with coronary heart disease
TL;DR: In patients with coronary disease testosterone deficiency is common and impacts significantly negatively on survival, and prospective trials of testosterone replacement are needed to assess the effect of treatment on survival.